医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Medical PDQ App is the Best Platform for COVID-19 Communication for Healthcare Providers and Patients

2020年03月13日 AM11:17
このエントリーをはてなブックマークに追加


 

FORT WORTH, Texas

With the uncontrollable global spread of the COVID-19 virus and quarantine orders from governments around the world, communication for healthcare providers and patients is becoming more challenging day after day. Agile Surgical Assistants, LLC believes Medical PDQ is the best mobile app platform for doctors and patients to connect without having to expose themselves to the coronavirus.

Fears of contracting and exposure of the COVID-19 virus, impacts the communication in the health industry for appointments and proper treatment for patients. Quarantine orders make it difficult for patients to schedule appointments while hospitals and clinics around the world are overwhelmed with an alarming rate of new cases everyday.

There is no cure or vaccine for COVID-19 but to aid in preventing the spread, communication is key. Medical PDQ provides a platform for communication amongst healthcare providers and patients for this type of outbreak. Healthcare providers can schedule patient’s appointments thru Medical PDQ, as well as direct message for consults, etc.

To aid in combatting and prevent the spread, Medical PDQ’s platform helps healthcare providers and their staff with clinic/surgery appointments, consults, emergencies, rescheduling and coverage requests, in real time. In matters of the pandemic spread of COVID-19, like any emergency, time is of the essence.

Start safely communicating (Android or iPhone) with your healthcare providers with MedicalPDQ.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200312005901/en/

CONTACT

Medical PDQ

Agile Surgical Assistants, LLC

Jacqueline Grant

CMO

contactus@medicalpdq.com

+1-888-637-3724 Ext 703

http://www.medicalpdq.com/

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024